[Is atrial fibrillation in heart failure relevant in prognosis? Pro rate control].
Schwerpunkt Klinische Elektrophysiologie, Klinik für Kardiologie und Pneumologie - Herzzentrum, Universitätsmedizin Göttingen.
M
M
Zabel
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D017115:Catheter Ablation; D003131:Combined Modality Therapy; D004562:Electrocardiography / Q000187:drug effects*; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000150:complications / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D011379:Prognosis; D015996:Survival Rate
D000889:Anti-Arrhythmia Agents